Javid Moslehi, MD

Dr. Moslehi is an Assistant Professor of Medicine and the Director of the Cardio-Oncology Program at Vanderbilt School of Medicine. Dr. Moslehi is an expert clinician on the management of cardiac complications associated with cancer therapies including chemotherapies (both traditional and novel) and radiation. Dr. Moslehis basic and translational research program is focused on the mechanisms of toxicities associated with novel targeted therapies and how this knowledge can be modulated to understand human cardiovascular biology. Arrhythmias have become a major concern in cancer drug development and with FDA approved therapies. One focus of the Vanderbilt Cardio-Oncology program and the Moslehi laboratory is better basic/mechanistic and clinical understanding of arrhythmias that result from cancer therapy. Projects include atrial fibrillation and other arrhythmias that result from kinase inhibitors, drugs that modulate proteasome medicated degradation, and radiation.For more questions regarding Vanderbilt Cardio-Oncology program or Dr. Moslehis laboratory, please email: javid.moslehi@vanderbilt.edu.